MedTrace Logo

A Facebook Intervention for Young Sexual and Gender Minority Smokers

NCT03259360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-01-30

No results posted yet for this study

Summary

The 2-year research plan will test the Put It Out Project (POP) in a pilot randomized trial (N=120) compared to TSP and two historical control conditions. Participants will be young adults who smoke, identify as sexual or gender minorities, and use Facebook. The primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 mos.

Conditions

  • Tobacco Use
  • Smoking
  • Tobacco Dependence
  • Tobacco Use Disorder
  • Tobacco Use Cessation
  • Tobacco Smoking
  • Smoking Cessation
  • Smoking, Cigarette
  • Smoking, Tobacco

Interventions

BEHAVIORAL

POP:

90 days of Facebook messaging, weekly live sessions targeting tobacco use and tailored to sexual and gender minority young adults

BEHAVIORAL

TSP:

90 days of Facebook messaging, weekly live sessions targeting tobacco use

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Gary L. Humfleet, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-23
Primary Completion
2019-04-20
Completion
2020-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03259360 on ClinicalTrials.gov